Mark Rothera Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Rothera.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Rothera. Mark Rothera is Chief Commercial Officer in PTC THERAPEUTICS, INC. ($PTCT).
Latest Insider Trading Transactions of Mark Rothera
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 3,001 | 32,561 | 146,999 | |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 4,099 | 44,474 | 10,001 | |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 900 | 9,765 | 14,100 | |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 46.90 | 3,000 | 140,700 | 9,000 | 12 K to 9 K (-25.00 %) |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 44.92 | 3,000 | 134,760 | 12,000 | 15 K to 12 K (-20.00 %) |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 44.15 | 7,100 | 313,465 | 15,000 | 22.1 K to 15 K (-32.13 %) |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 3,001 | 32,561 | 22,100 | 19.1 K to 22.1 K (+15.71 %) |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 4,099 | 44,474 | 19,099 | 15 K to 19.1 K (+27.33 %) |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 42.88 | 2,000 | 85,760 | 15,000 | 17 K to 15 K (-11.76 %) |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 43.86 | 900 | 39,474 | 17,000 | 17.9 K to 17 K (-5.03 %) |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 900 | 9,765 | 17,900 | 17 K to 17.9 K (+5.29 %) |
Sep 16 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 36.41 | 1,840 | 66,994 | 17,000 | 18.8 K to 17 K (-9.77 %) |
Sep 16 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 35.72 | 3,160 | 112,875 | 18,840 | 22 K to 18.8 K (-14.36 %) |
Sep 16 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 36.68 | 3,000 | 110,040 | 22,000 | 25 K to 22 K (-12.00 %) |
Jan 31 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | A | 27.05 | 65,000 | 1,758,250 | 65,000 |
Page: 1